Imaging Essentials Before VAD Placement
... 2. Review the importance of detecting intra-cardiac shunting in patients undergoing VAD placement. 3. Discuss the clinical significance of valvular regurgitation in patients undergoing VAD placement. ...
... 2. Review the importance of detecting intra-cardiac shunting in patients undergoing VAD placement. 3. Discuss the clinical significance of valvular regurgitation in patients undergoing VAD placement. ...
Ch 21: Cardiovascular System - The Heart -
... the brighter the color the greater the blood flow through tissue ...
... the brighter the color the greater the blood flow through tissue ...
From SICSA website - Robert Gordon University
... Elevated blood glucose and high circulating cholesterol cause damage to the heart resulting in changes in the structure and function of the heart muscle (myocardial fibrosis), resulting in cardiac failure and increased morbidity. A key event in myocardial fibrosis is an imbalance between the synthes ...
... Elevated blood glucose and high circulating cholesterol cause damage to the heart resulting in changes in the structure and function of the heart muscle (myocardial fibrosis), resulting in cardiac failure and increased morbidity. A key event in myocardial fibrosis is an imbalance between the synthes ...
18 - FacultyWeb Support Center
... • Electrocardiogram (ECG or EKG): a composite of all the action potentials generated by nodal and contractile cells at a given time • Three waves 1. P wave: depolarization of SA node 2. QRS complex: ventricular depolarization 3. T wave: ventricular repolarization ...
... • Electrocardiogram (ECG or EKG): a composite of all the action potentials generated by nodal and contractile cells at a given time • Three waves 1. P wave: depolarization of SA node 2. QRS complex: ventricular depolarization 3. T wave: ventricular repolarization ...
B1 Atrial Fibrillation
... - characterized by extremely rapid (300-600 bmp) and disorganized atrial activation. AV node filters this, resulting in a fast, irregular ventricular rate of 100-120 bpm - ventricular rate: atrial rate is 1:3; if know the ventricular rate (i.e. heart rate) then know the approximate atrial rate - may ...
... - characterized by extremely rapid (300-600 bmp) and disorganized atrial activation. AV node filters this, resulting in a fast, irregular ventricular rate of 100-120 bpm - ventricular rate: atrial rate is 1:3; if know the ventricular rate (i.e. heart rate) then know the approximate atrial rate - may ...
Pak Heart J - Pakistan Heart Journal
... patients, and there have been no studies to confirm the differences of Tei-index and Z ratio among patients with chronic heart failure. Tei-index expresses the ratio between total isovolumic and ejection times, while Z ratio the proportion of the cardiac cycle during which the left ventricle is eith ...
... patients, and there have been no studies to confirm the differences of Tei-index and Z ratio among patients with chronic heart failure. Tei-index expresses the ratio between total isovolumic and ejection times, while Z ratio the proportion of the cardiac cycle during which the left ventricle is eith ...
Regional Differences in Heart Failure with Preserved Ejection
... In the Americas group, compared with placebo, spironolactone decreased the primary outcome 18% from 12.6% to 10.4% (p = 0.026), decreased cardiovascular mortality 26% from 14.4% to 10.8% (p =0.027), decreased hospitalization for heart failure 18% from 24.5% to 20.8% (p =0.042), decreased recurrent h ...
... In the Americas group, compared with placebo, spironolactone decreased the primary outcome 18% from 12.6% to 10.4% (p = 0.026), decreased cardiovascular mortality 26% from 14.4% to 10.8% (p =0.027), decreased hospitalization for heart failure 18% from 24.5% to 20.8% (p =0.042), decreased recurrent h ...
congestive heart failure in children: a survey of 114 patients
... hundred and fourteen patients with congestive heart failure (CHF) were admitted to the pediatric department of Taleghani General Hospital. Ouring the above period, 192 patients with heart disease were hospitalized at this department and CHF was the cause of admission in 59.4% of them. Congenital hea ...
... hundred and fourteen patients with congestive heart failure (CHF) were admitted to the pediatric department of Taleghani General Hospital. Ouring the above period, 192 patients with heart disease were hospitalized at this department and CHF was the cause of admission in 59.4% of them. Congenital hea ...
Paediatric cardiology
... • Paediatric PE risk factors – indwelling CVL; prothrombotic; FHx of thrombosis, surgery or immobility > 3 days in last ...
... • Paediatric PE risk factors – indwelling CVL; prothrombotic; FHx of thrombosis, surgery or immobility > 3 days in last ...
Document
... abnormal electrical conduction that changes the heart rate and rhythm. A disturbance in the heart’s rhythm. ► Why? Causes? 1) Classified according to their origin 2) Some are mild, asymptomatic – require no treatment 3) Some are catastrophic – require immediate emergency response 4) They can influen ...
... abnormal electrical conduction that changes the heart rate and rhythm. A disturbance in the heart’s rhythm. ► Why? Causes? 1) Classified according to their origin 2) Some are mild, asymptomatic – require no treatment 3) Some are catastrophic – require immediate emergency response 4) They can influen ...
Drugs for Heart Failure
... may be caused by weakened heart muscle. Identify drug classes that are used for first- and secondchoice pharmacotherapy of heart failure. ...
... may be caused by weakened heart muscle. Identify drug classes that are used for first- and secondchoice pharmacotherapy of heart failure. ...
Presentation Example 2
... Also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours). It has also been shown in the treatment of heart failure. ...
... Also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours). It has also been shown in the treatment of heart failure. ...
PA Lines - HeartFailure
... pulmonary artery catheters have not been shown to improve outcomes.” • However, there are situations in which pulmonary artery catheterization may be helpful to manage and assess patients ...
... pulmonary artery catheters have not been shown to improve outcomes.” • However, there are situations in which pulmonary artery catheterization may be helpful to manage and assess patients ...
Lecture 9 th , 10 th week
... • SV is the amount of blood transferred from LV to the arterial system during systole • In healty person SV should be > 60 ml EF (ejection fraction) = SV / EDV (normally about 55% - 75%) • EF is an important measurement of cardiac efficiency • EF is used clinically to assess cardiac status in patien ...
... • SV is the amount of blood transferred from LV to the arterial system during systole • In healty person SV should be > 60 ml EF (ejection fraction) = SV / EDV (normally about 55% - 75%) • EF is an important measurement of cardiac efficiency • EF is used clinically to assess cardiac status in patien ...
What Have We Learned About Cardiac Arrhythmias?
... for prolonging the QT interval in the acquired and inherited LQTS and initiating torsades de pointes.18 Increased heart rate and magnesium suppress EADs, which explains the therapeutic efficacy of those treatments in the acquired LQTS. Late or delayed afterdepolarizations may be responsible for some ...
... for prolonging the QT interval in the acquired and inherited LQTS and initiating torsades de pointes.18 Increased heart rate and magnesium suppress EADs, which explains the therapeutic efficacy of those treatments in the acquired LQTS. Late or delayed afterdepolarizations may be responsible for some ...
IV-29 9.01 R. Lidocaine Hydrochloride (Xylocaine®)
... A. Ventricular dysrhythmias, Cardiac arrest, Post cardioversion/defibrillation of ventricular rhythm [by online MD order only] •1 mg/kg slow IV/IO over 1 minute or 2 mg/kg ET. If no conversion, repeat 1 mg/kg IV/IO two times or 1 mg/kg ET one time in 3-5 minutes. (Maximum 3 mg/kg). VI ...
... A. Ventricular dysrhythmias, Cardiac arrest, Post cardioversion/defibrillation of ventricular rhythm [by online MD order only] •1 mg/kg slow IV/IO over 1 minute or 2 mg/kg ET. If no conversion, repeat 1 mg/kg IV/IO two times or 1 mg/kg ET one time in 3-5 minutes. (Maximum 3 mg/kg). VI ...
The Befores and Afters of Arrhythmias and Hypertrophic
... system Electrical signal will just travel through loop over and over Loops can be big or small ...
... system Electrical signal will just travel through loop over and over Loops can be big or small ...
Telemetry/EKG/Pacers
... 3. no metal detectors or no longer than nec. 4. MRI interrupts pacing-can’t get one for some time if new 5. No power generators (welding) 6. microwave questionable 7. radiotherapy (may damage circuits) The pacer may need to be surgically moved if in path of radiation field. 8. TENS (transcutaneous e ...
... 3. no metal detectors or no longer than nec. 4. MRI interrupts pacing-can’t get one for some time if new 5. No power generators (welding) 6. microwave questionable 7. radiotherapy (may damage circuits) The pacer may need to be surgically moved if in path of radiation field. 8. TENS (transcutaneous e ...
Images and Case Reports in Heart Failure
... registered with the fluoroscopic images during the procedure to guide device implantation. A 23-year-old man with a history of repair of hemianomalous pulmonary venous drainage and biventricular noncompaction (Figure 1A and B) presented with a 3-month history of reduced exercise tolerance and periph ...
... registered with the fluoroscopic images during the procedure to guide device implantation. A 23-year-old man with a history of repair of hemianomalous pulmonary venous drainage and biventricular noncompaction (Figure 1A and B) presented with a 3-month history of reduced exercise tolerance and periph ...
Some clinical indicators of heart disease during Pregnancy
... Class 2 : Slightly compromised , slight limitation of physical activity Class 3 : Markedly compromised , marked limitation of physical activity Class 4 : Severely compromised , inability to perform any physical activity without discomfort ...
... Class 2 : Slightly compromised , slight limitation of physical activity Class 3 : Markedly compromised , marked limitation of physical activity Class 4 : Severely compromised , inability to perform any physical activity without discomfort ...
second-degree heart block (second-degree atrioventricular block
... The heart of the dog or cat is composed of four chambers; the top two chambers are the right and left atria and the bottom two chambers are the right and left ventricles In order to pump blood to the lungs and body, the heart must work in a coordinated fashion; the normal control or “pacemaker” ...
... The heart of the dog or cat is composed of four chambers; the top two chambers are the right and left atria and the bottom two chambers are the right and left ventricles In order to pump blood to the lungs and body, the heart must work in a coordinated fashion; the normal control or “pacemaker” ...
Downloadable PPT - Research To Practice
... associated with rituximab therapy, and patients also received acyclovir prophylaxis, which is important with proteasome inhibitors because of the significant risk of herpes zoster associated with administration of these agents. The authors reported an 81% response rate — 1 patient experienced a CR, ...
... associated with rituximab therapy, and patients also received acyclovir prophylaxis, which is important with proteasome inhibitors because of the significant risk of herpes zoster associated with administration of these agents. The authors reported an 81% response rate — 1 patient experienced a CR, ...
Options for the “No-Option” Refractory Angina Patient - Cedars
... tetralogy of Fallot. The criteria for re-operation on these patients, mostly for pulmonary valve replacement, is in the process of being redefined. It was once believed that a patient with repaired tetralogy of Fallot would not need another operation. However, it has become apparent that a portion o ...
... tetralogy of Fallot. The criteria for re-operation on these patients, mostly for pulmonary valve replacement, is in the process of being redefined. It was once believed that a patient with repaired tetralogy of Fallot would not need another operation. However, it has become apparent that a portion o ...
apch20.ppt
... • Internodal pathway slows this signal ‘just a bit’ to allow atria time to complete contraction • Signal reaches AV node causing it to fire an impulse down the… • AV bundle (left & right branches) • Signal reaches heart apex and travels back up walls of ventricles causing them to contract ...
... • Internodal pathway slows this signal ‘just a bit’ to allow atria time to complete contraction • Signal reaches AV node causing it to fire an impulse down the… • AV bundle (left & right branches) • Signal reaches heart apex and travels back up walls of ventricles causing them to contract ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.